Saudi Pharmaceutical Industries and Medical Appliances Corporation (2070.SR)
SAR 31.65
(-0.32%)
SAR 31.65
(-0.32%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 575 Million SAR | 44.24% |
| 2022 | 398.63 Million SAR | -8.32% |
| 2021 | 434.81 Million SAR | -34.3% |
| 2020 | 661.78 Million SAR | -8.17% |
| 2019 | 720.63 Million SAR | 50.41% |
| 2018 | 479.11 Million SAR | -29.73% |
| 2017 | 681.84 Million SAR | 1.12% |
| 2016 | 674.26 Million SAR | 0.0% |
| 2015 | - SAR | 0.0% |
| 2014 | - SAR | 0.0% |
| 2013 | - SAR | 0.0% |
| 2012 | - SAR | 0.0% |
| 2011 | - SAR | 0.0% |
| 2010 | - SAR | 0.0% |
| 2009 | - SAR | 0.0% |
| 2008 | - SAR | 0.0% |
| 2007 | - SAR | 0.0% |
| 2006 | - SAR | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | 576 Million SAR | 0.18% |
| 2024 Q2 | 529.21 Million SAR | -8.17% |
| 2023 Q3 | 665.45 Million SAR | -9.84% |
| 2023 Q2 | 738.1 Million SAR | 146.54% |
| 2023 Q1 | 299.38 Million SAR | -24.9% |
| 2023 Q4 | 575 Million SAR | -13.59% |
| 2023 FY | 575 Million SAR | 44.24% |
| 2022 Q4 | 398.63 Million SAR | -5.49% |
| 2022 FY | 398.63 Million SAR | -8.32% |
| 2022 Q1 | 529.61 Million SAR | 21.8% |
| 2022 Q2 | 419.91 Million SAR | -20.71% |
| 2022 Q3 | 421.78 Million SAR | 0.45% |
| 2021 Q1 | 658.46 Million SAR | -0.5% |
| 2021 FY | 434.81 Million SAR | -34.3% |
| 2021 Q3 | 634.19 Million SAR | 9.75% |
| 2021 Q4 | 434.81 Million SAR | -31.44% |
| 2021 Q2 | 577.84 Million SAR | -12.24% |
| 2020 Q4 | 661.78 Million SAR | 2.01% |
| 2020 FY | 661.78 Million SAR | -8.17% |
| 2020 Q2 | 657.46 Million SAR | -4.99% |
| 2020 Q3 | 648.75 Million SAR | -1.32% |
| 2020 Q1 | 692 Million SAR | -3.97% |
| 2019 Q1 | 611.12 Million SAR | 27.55% |
| 2019 FY | 720.63 Million SAR | 50.41% |
| 2019 Q4 | 720.63 Million SAR | 9.99% |
| 2019 Q3 | 655.2 Million SAR | -4.91% |
| 2019 Q2 | 689.05 Million SAR | 12.75% |
| 2018 Q1 | 621.12 Million SAR | -8.91% |
| 2018 FY | 479.11 Million SAR | -29.73% |
| 2018 Q2 | 621.12 Million SAR | 0.0% |
| 2018 Q3 | 650.4 Million SAR | 4.71% |
| 2018 Q4 | 479.11 Million SAR | -26.34% |
| 2017 Q3 | 618.31 Million SAR | -0.01% |
| 2017 Q1 | 618.55 Million SAR | -8.26% |
| 2017 FY | 681.84 Million SAR | 1.12% |
| 2017 Q4 | 681.84 Million SAR | 10.28% |
| 2017 Q2 | 618.36 Million SAR | -0.03% |
| 2016 Q3 | 658.72 Million SAR | 49.23% |
| 2016 Q2 | 441.4 Million SAR | 451.76% |
| 2016 Q1 | 80 Million SAR | 0.0% |
| 2016 FY | 674.26 Million SAR | 0.0% |
| 2016 Q4 | 674.26 Million SAR | 2.36% |
| 2015 Q3 | - SAR | 0.0% |
| 2015 FY | - SAR | 0.0% |
| 2015 Q4 | - SAR | 0.0% |
| 2015 Q2 | - SAR | 0.0% |
| 2015 Q1 | - SAR | 0.0% |
| 2014 FY | - SAR | 0.0% |
| 2014 Q4 | - SAR | 0.0% |
| 2014 Q3 | - SAR | 0.0% |
| 2014 Q2 | - SAR | 0.0% |
| 2014 Q1 | - SAR | 0.0% |
| 2013 Q4 | - SAR | 0.0% |
| 2013 FY | - SAR | 0.0% |
| 2013 Q1 | - SAR | 0.0% |
| 2013 Q2 | - SAR | 0.0% |
| 2013 Q3 | - SAR | 0.0% |
| 2012 Q4 | - SAR | 0.0% |
| 2012 FY | - SAR | 0.0% |
| 2012 Q3 | - SAR | 0.0% |
| 2011 FY | - SAR | 0.0% |
| 2010 FY | - SAR | 0.0% |
| 2009 FY | - SAR | 0.0% |
| 2008 FY | - SAR | 0.0% |
| 2007 FY | - SAR | 0.0% |
| 2006 FY | - SAR | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Jamjoom Pharmaceuticals Factory Company | 2.15 Million SAR | -26577.282% |